Karolinska Schizophrenia Project

Recruiting Observational Study
Schizophrenia and Disorders with Psychotic Features
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Healthy Volunteers Welcome You do not need to have the condition being studied to take part. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Observational
Participants needed
200 (estimated)
Sponsor
Karolinska Institutet · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

KaSP is a multimodal observational study with the goal of clarifying underlying mechanisms that cause psychotic disorders, such as schizophrenia. Participants with psychotic symptoms are recruited early after first contact with health care, within 4 weeks of starting anti-psychotic medication, and are compared to controls without psychiatric diagnoses on several measures.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: For FEP: * Diagnosis as assessed using DSM-IV of one of the following: schizophrenia, schizophreniform psychosis, psychosis not otherwise specified (NOS), brief psychosis, schizoaffective syndrome, delusional disorder * First exposure to anti-psychotic medication less than 4 we…
Contacts

Carl M Sellgren, MD, PhD

+46 702127287

carl.sellgren@ki.se

CONTACT

Lena Lundberg

+46725223907

lena.lundberg.2@ki.se

CONTACT